GenVec's P2P Acquisition

GenVec raised a round of funding on June 16, 2017. Investors include Intrexon.

GenVec (NASDAQ: GNVC) is a clinical-stage biopharmaceutical company and pioneer in the development of AdenoVerse gene delivery technology platform.…

Articles about GenVec's P2P Acquisition: